Newsroom

Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer

September 16, 2025

62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse statement Nationally, HPV vaccination coverage has stagnated, falling short of national goals

Today, �鶹ӳ�� MD Anderson Cancer Center, along with 61 National Cancer Institute (NCI)-Designated Cancer Centers, leading national organizations and the University of Puerto Rico Comprehensive...

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

BY Clayton Boldt

September 05, 2025

Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies Phoenix receives a supply of...

Novel tool helps identify key targets to strengthen CAR NK cell therapies

BY Jade Waddy

August 21, 2025

Researchers developed the first genome-wide CRISPR screening tool for primary human natural killer (NK) cells Study revealed critical regulators...

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

August 20, 2025

Study finds cancer cells break down protective nerve coverings, leading to nerve injury and chronic inflammation These nerve injuries drive immune exhaustion and immunotherapy resistance Targeting the cancer-induced nerve injury pathway can reverse resistance and improve treatment response Findings highlight importance of studying cancer neuroscience �C the interactions between cancer and the nervous system

Cancer cells can break down...

MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

BY Clayton Boldt

July 29, 2025

3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies Teams will evaluate technology...